About APITBIO

Company History
2020

06/08CDMO contract for entering non-clinical and clinical test of APB-A001 (Binex)

01/17Website Renewal

2019

12/03Office Relocation (Tera Tower 1, Munjeong-dong, Songpa-gu)

11/26Research Institute Cerificate

08/22Venture Company Certificate

08/21Six Trademark Applications (South Korea)

08/08Signed Technology Transfer Agreement. MOU with the Kangwon National University Industry Cooperation Foundation

07/23Seed Investor Agreement (Kolon Investment : 2 billion KRW, Neoplux : 2 billion KRW

07/22T-cell receptor(TCR) Study Contract with Charles River

06/27PCT Patent Application for target immuno-therapeutics

06/24U.S.Provisional Patents Application for target immuno-therapeutics

06/14Small and Medium-sized Enterprise Certificate

05/13Office Relocation (Munjeong-dong, Songpa-gu, Seoul)

03/26Strategic Investment Contract (C&R Research Inc. : 500 million KRW)

03/04Technology Transfer Agreement : Target Immuno-therapeutics (The Industry Academy Cooperation Foundation of Kangwon National University Technology)

2018

12/13Establishment of APITBIO Inc. (Daechi-dong, Gangnam-gu, Seoul)

TOP